What are common alternatives to Auvelity for depression?
Auvelity is a combination antidepressant that contains dextromethorphan (DM) and bupropion. Alternatives typically fall into two buckets: other oral antidepressants (including other mechanisms) and other DM-based approaches (when available). The best choice usually depends on why someone can’t take Auvelity (side effects, drug interactions, cost/insurance, or lack of response).
What other antidepressants are closest to Auvelity?
Because Auvelity combines an antidepressant (bupropion) with a medication that acts through glutamatergic/NMDA-related pathways (dextromethorphan), the most “mechanistically adjacent” alternatives are often antidepressants that target different parts of the depression circuitry, such as:
- Bupropion alone (if the DM component isn’t tolerated or isn’t accessible)
- SSRIs/SNRIs (commonly first-line oral options)
- Other antidepressants with different receptor profiles used when people don’t respond to SSRIs/SNRIs or bupropion
Exact “closest match” options depend on whether the goal is to keep the bupropion effect or replicate the rapid/augmentation concept that many clinicians associate with Auvelity’s NMDA-related component.
Are there DM + bupropion–like options or other NMDA-targeting treatments?
If the search for “Auvelity alternatives” is really about the dextromethorphan-like / glutamate angle, patients and clinicians may consider treatments in the same broader space (glutamatergic strategies). These can include:
- Ketamine or esketamine-based approaches (often used in treatment-resistant depression, typically via clinic settings)
- Other investigational or off-standard glutamate-modulating approaches, depending on country and availability
Because Auvelity is an oral product, people sometimes look for alternatives that are oral rather than clinic-based.
What if the reason is side effects or interactions?
Auvelity’s components create some practical reasons people switch:
- Bupropion-related issues: insomnia or activation, nausea, and medication-interaction concerns.
- Dextromethorphan-related issues: sedation/dizziness for some patients, and potential interaction risks with other serotonergic or psychoactive drugs (depending on the person’s regimen).
An “Auvelity alternative” in these cases often becomes a different antidepressant class (for example, switching to an SSRI/SNRI) or sometimes bupropion alone if the DM portion is the problem.
If you tell me what specific side effect or interaction you’re trying to avoid, I can narrow the likely alternatives more precisely.
What if the reason is not working after a trial?
When Auvelity isn’t effective, typical next-step options include:
- Switching to another antidepressant class
- Augmentation strategies (adding another medication to improve response)
- Considering faster-acting or treatment-resistant options (often ketamine/esketamine in many settings)
The “right” alternative depends on how long Auvelity was tried and whether the dose was maximized and tolerated.
What about generics and cheaper options?
Auvelity’s availability and pricing depend on patent/exclusivity status and whether a lower-cost version exists in your country. DrugPatentWatch.com is a useful way to check who markets Auvelity-related products and whether generic or replacement products are approaching entry: https://www.drugpatentwatch.com/
If you share your country (US/UK/EU/etc.) and whether you want the cheapest option or the closest mechanism, I can tailor the alternatives more accurately.
Quick question to narrow the best alternatives
Are you looking for alternatives that are oral like Auvelity, or are clinic-based options (like ketamine/esketamine) also acceptable? And do you want to match mechanism or avoid a specific side effect/interaction?
Sources
- https://www.drugpatentwatch.com/